To access this element change to forms mode OFF

Grant Award View - GA28394

Do sex steroids regulate tear lipid production in human meibomian...

Contact Details

ARC NCGP General Enquiries

:
02 6287 6600

:

GA ID:
GA28394
Agency:
Australian Research Council
Approval Date:
27-Nov-2018
Publish Date:
18-Dec-2018
Category:
Science, Technology, Engineering and Mathematics (STEM) Research
Grant Term:
1-Sep-2019 to 31-Aug-2023
Original: 1-Jan-2019 to 31-Dec-2021
Value (AUD):
$450,000.00 (GST inclusive where applicable)
Variations:

One-off/Ad hoc:
No
Aggregate Grant Award:
No

PBS Program Name:
ARC 18/19 Discovery
Grant Program:
Discovery Projects
Grant Activity:
Do sex steroids regulate tear lipid production in human meibomian glands?
Purpose:
This project aims to determine whether production of tear film lipids by meibomian gland cells is regulated by sex steroids. The tear film is essential to eyesight. It protects and nourishes the eye surface to maintain transparency to enable light to reach the retina. To guarantee these functions, exquisite control of tear film composition is required, including the outer lipid layer. Sex hormones, including oestrogen, may control production of the lipid layer by meibomian glands in the eyelid, but this has not been confirmed in humans. This project aims to show whether meibomian glands produce sex hormones, which then control production of tear lipids. This new knowledge will improve our understanding of how the tear film maintains clear vision.

GO ID:
GO Title:
Discovery Projects commencing in 2019
Internal Reference ID:
DP19 Round 1
Selection Process:
Targeted or Restricted Competitive

Confidentiality - Contract:
No
Confidentiality - Outputs:
No

Grant Recipient Details

Recipient Name:
The University of New South Wales
Recipient ABN:
57 195 873 179

Grant Recipient Location

Suburb:
KENSINGTON
Town/City:
KENSINGTON
Postcode:
2033
State/Territory:
NSW
Country:
AUSTRALIA

Grant Delivery Location

State/Territory:
NSW
Postcode:
2033
Country:
AUSTRALIA

Contact Details

ARC NCGP General Enquiries

:
02 6287 6600

: